Sun Pharmaceutical Industries Inc. is voluntarily recalling approximately 47,500 vials of Testosterone Cypionate Injection (200 mg/mL). The recall was initiated due to a manufacturing deviation that resulted in a microbial excursion, meaning the sterility of the product cannot be guaranteed. No injuries or adverse incidents have been reported to date. This prescription medication is used for testosterone replacement therapy and was distributed nationwide in the United States.
Using a medication intended for injection that is not sterile can lead to serious health complications, including localized infections or life-threatening systemic infections like sepsis. While no illnesses have been reported, the manufacturing defect poses a potential risk to anyone who receives an injection from the affected batch.
You have 2 options:
Recall #: D-1154-2022; Manufactured by Sun Pharmaceutical Industries Ltd., Gujarat, India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.